The clinical impression of severity index for Parkinson's disease: International validation study

2009 ◽  
Vol 24 (2) ◽  
pp. 211-217 ◽  
Author(s):  
Pablo Martínez-Martín ◽  
Carmen Rodríguez-Blázquez ◽  
Maria João Forjaz ◽  
Jesús de Pedro ◽  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Validation Study ◽  
Severity Index ◽  
Clinical Impression

Parkinson's disease sleep scale: Validation study of a Spanish version

2004 ◽  
Vol 19 (10) ◽  
pp. 1226-1232 ◽  
Author(s):  
Pablo Martínez-Martín ◽  
Carlos Salvador ◽  
Luis Menéndez-Guisasola ◽  
Sonia González ◽  
Aurelio Tobías ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Validation Study ◽  
Scale Validation ◽  
Spanish Version

Extensive validation study of the Parkinson's Disease Composite Scale

2019 ◽  
Vol 26 (10) ◽  
pp. 1281-1288 ◽  
Author(s):  
P. Martinez‐Martin ◽  
F. G. Radicati ◽  
C. Rodriguez Blazquez ◽  
J. Wetmore ◽  
N. Kovacs ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Validation Study ◽  
Composite Scale

Clinically relevant cut-off values for the Parkinson's Disease Sleep Scale-2 (PDSS-2): a validation study

2016 ◽  
Vol 24 ◽  
pp. 87-92 ◽  
Author(s):  
Maria-Lucia Muntean ◽  
Heike Benes ◽  
Friederike Sixel-Döring ◽  
Kallol Ray Chaudhuri ◽  
Keisuke Suzuki ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Validation Study

Satisfaction with Life Scale (SLS-6): First validation study in Parkinson's disease population

2016 ◽  
Vol 25 ◽  
pp. 52-57 ◽  
Author(s):  
Leire Ambrosio ◽  
Mari Carmen Portillo ◽  
Carmen Rodriguez-Blazquez ◽  
Juan Carlos Martínez-Castrillo ◽  
Mayela Rodriguez-Violante ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Validation Study ◽  
Satisfaction With Life ◽  
Satisfaction With Life Scale ◽  
Life Scale

Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale

2014 ◽  
Vol 261 (12) ◽  
pp. 2319-2328 ◽  
Author(s):  
Gabriella Santangelo ◽  
Paolo Barone ◽  
Sofia Cuoco ◽  
Simona Raimo ◽  
Domenica Pezzella ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Validation Study ◽  
De Novo

scholarly journals Erratum to: Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale

2014 ◽  
Vol 261 (12) ◽  
pp. 2329-2329 ◽  
Author(s):  
Gabriella Santangelo ◽  
Paolo Barone ◽  
Sofia Cuoco ◽  
Simona Raimo ◽  
Domenica Pezzella ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Validation Study ◽  
De Novo

scholarly journals Parkinson's disease-related pattern (PDRP) identified using resting-state functional MRI: Validation study

2021 ◽  
Vol 1 (3) ◽  
pp. 100026
Author(s):  
Andrea Rommal ◽  
An Vo ◽  
Katharina A. Schindlbeck ◽  
Andrea Greuel ◽  
Marina C. Ruppert ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Functional Mri ◽  
Validation Study ◽  
Resting State ◽  
Related Pattern

scholarly journals Insomnia and autonomic dysfunction may identify patients at risk for developing early Parkinson's disease dementia

2019 ◽  
Author(s):  
Anamaria Jurcau ◽  
Vharoon Sharma Nunkoo
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Autonomic Dysfunction ◽  
Odds Ratio ◽  
Rating Scale ◽  
Demographic Data ◽  
Severity Index ◽  
Complex Evaluation ◽  
Patients At Risk

Abstract Background: The prospective study aims at identifying features predictive of early onset of dementia in patients with Parkinson's disease (PD). Methods: 89 non-demented PD patients underwent a complex evaluation (demographic data, UPDRS, Unified Multiple System Atrophy Rating Scale - UMSAR, Insomnia Severity Index - ISI, Neuro-Psychiatric Inventory - NPI, Hamilton Depression Rating Scale - HDRS, Mini Mental State Examination) at baseline and at 3-year follow-up. Results: At 3-year follow-up 43.8% of patients developed dementia. An ordinal regression of MMSE at follow-up showed that dementia developed in patients with autonomic dysfunctions (odds ratio 16.18, 95% CI 3.16 to 82.77, p = 0.001), old age (odds ratio 1.24, 95% CI 1.11 to 1.39, p < 0.001), and insomnia (odds ratio 1.23, 95% CI 1.09 to 1.38, p = 0.001). Conclusion: Patients with signs of autonomic dysfunction and insomnia are at higher risk for developing dementia and deserve closer monitoring of cognitive symptoms.

BRAIN GLUTAMATE DECARBOXYLASE IN PARKINSON'S DISEASE WITH PARTICULAR REFERENCE TO A PREMORTEM SEVERITY INDEX

Brain ◽  
1985 ◽  
Vol 108 (2) ◽  
pp. 301-313 ◽  
Author(s):  
J. C. MONFORT ◽  
F. JAVOY-AGID ◽  
J. J. HAUW ◽  
B. DUBOIS ◽  
Y. AGID
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Glutamate Decarboxylase ◽  
Severity Index
Sign in / Sign up

Export Citation Format

Share Document